Chester County News and Community Website
IMMACULATA UNIVERSITY, PA — Immaculata University has entered into a partnership with Gwynedd Mercy University to create a pathway for students to enroll in the Doctorate of Nursing Practice (DNP) and the Master …
Read More
CHESTER COUNTY, PA — The Pennsylvania National Electronic Disease Surveillance System (PA-NEDSS) today confirmed 39 additional positive cases of COVID-19 in Chester County, bringing the countywide total to 2,823, which …
Read More
WASHINGTON, D.C. — As part of the Trump Administration’s Operation Warp Speed, on Monday, the U.S. Department of Health and Human Services announced a task order with Emergent BioSolutions to …
Read More
MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN), a clinical-stage company focused on discovering, developing and commercializing transformative therapies to treat the whole eye, today announced the decision to discontinue the …
Read More
WASHINGTON, D.C. — A federal judge has ordered two individuals doing business as Sundial Herbal Products to stop distributing unapproved new drugs and misbranded drugs until they comply with federal …
Read More
WASHINGTON D.C. — The U.S. Department of Veterans Affairs (VA) has begun a national four-year study on the impact of COVID-19 on Veterans to help address critical questions about the …
Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration recently took steps to further support the development of COVID-19 tests for at-home self-collection by including a voluntary EUA template for …
Read More
CHESTER COUNTY, PA — The Pennsylvania National Electronic Disease Surveillance System (PA-NEDSS) today confirmed 55 additional positive cases of COVID-19 in Chester County, bringing the countywide total to 2,784, which …
Read More
MALVERN, PA — PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies for cardiopulmonary diseases, announced FDA authorization to proceed with …
Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration granted approval to Oriahnn (an estrogen and progestin combination product consisting of elagolix, estradiol and norethindrone acetate) capsules, co-packaged for oral …
Read More